-
Product Insights
Ir. H. Djuanda
Ir. H. Djuanda is a Hydro project located in West Java, Indonesia. The project came online in 1967. Empower your strategies with our Ir. H. Djuanda report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Insulin Glargine + Insulin Lispro) LA in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Insulin Glargine + Insulin Lispro) LA in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Insulin Glargine + Insulin Lispro) LA...
-
Product Insights
NewNet Present Value Model: Xenon Pharmaceuticals Inc’s Ezogabine IR
Empower your strategies with our Net Present Value Model: Xenon Pharmaceuticals Inc's Ezogabine IR report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Analyst Opinions
Agile IT – How Software-Defined Everything (SDx) Transforms Enterprise Fabric
Software-Defined Everything (SDx) Technology Overview Software-Defined Everything (SDx) is the key to managing enterprise IT infrastructure challenges. SDx technologies enable dynamic resource allocation, centralized management, security enhancement, agile provisioning, and integration with modern applications, fostering infrastructure efficiency and resilience. "Agile IT - How Software-Defined Everything (SDx) Transforms Enterprise Fabric" innovation radar report explores the pervasive influence of software-defined technologies across various sectors such as automotive, technology, telecom, aerospace & defense, manufacturing, energy & power, and consumer & retail. This report...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BB-1701 in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BB-1701 in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BB-1701 in...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dipraglurant IR in Blepharospasm
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dipraglurant IR in Blepharospasm report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Dipraglurant IR in BlepharospasmDrug Details:Dipraglurant IR (ADX-48621) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ir-CPI in Thrombosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ir-CPI in Thrombosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ir-CPI in Thrombosis Drug Details: Ir-CPI is under development of for the treatment...
-
Company Insights
Innovation and Patenting activity of IR Japan Holdings Ltd Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of IR Japan Holdings Ltd Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ir-CPI in Intracerebral Hemorrhage
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ir-CPI in Intracerebral Hemorrhage report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ir-CPI in Intracerebral Hemorrhage Drug Details: Ir-CPI is under development of for...